NeuroRPM
PrivateLast Round
Accelerator
Sep 19, 2024
Total Funding Raised
$2,500
Company Overview
NeuroRPM is a medtech company that has developed an FDA-cleared, AI-powered remote monitoring application for Parkinson's disease that works with the Apple Watch.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Telemedicine, Medical AI, Health IoT
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroRPM Comparables
Compare NeuroRPM with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rune Labs | 93% | |
| BioSensics | 82% | |
| Modality.AI | 67% | |
NeuroRPM Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 19, 2024 |
NeuroRPM Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AgeTech Collaborative | Accelerator |
| DC Department of Small and Local Business Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2025
Monthly visitors grew 63% MoM, reaching 1K.
- Apr 1, 2025
Monthly visitors increased 41% MoM.
NeuroRPM Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroRPM's valuation, stock price, and market status.